NEW YORK (GenomeWeb) – Great Basin announced today that its Bordetella Direct assay has received CE Marking.

The PCR-based test to detect Bordetella pertussis was granted 510(k) clearance by the US Food and Drug Administration earlier this year and will now be launched commercially.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.